Your Location:
Home >
Browse articles >
Effect of Qinyu Sanlong Decoction on Expression of SFRP-2 Antagonistic Wnt Signal Pathway
Effect of Qinyu Sanlong Decoction on Expression of SFRP-2 Antagonistic Wnt Signal Pathway
- Chinese Journal of Experimental Traditional Medical Formulae Vol. 24, Issue 7, Pages: 127-132(2018)
DOI: 10.13422/j.cnki.syfjx.20180793
Scan QR Code
Full Text(HTML)
Publication Info
Metrics
38
Views
83
Downloads
2
CSCD
Alert me when the article has been cited
Submit
Tools
- BibTeXDownload
- EndnoteDownload
- RefMan Download
- NoteExpressDownload
- NoteFirstDownload
Related Articles
Effect of Qiyu Sanlong Decoction in Inhibiting Growth of Lung Cancer by Regulating Expressions of Beclin1, Atg5 and LC3B
Mechanism of Feiyanning Formula in Suppressing Invasion and Metastasis of Lung Cancer Cells via Modulating Exosomal miR-328 and STAT3/c-Fos/NFATc1 Pathway
Research on Patterns of Syndrome Differentiation and Treatment for Lung Cancer Based on Case Reports: An Evidence-based Pathway Exploration for Complementing Clinical Guidelines
Wisdom Inheritance of Distinguished Physicians' Experience Through Integration of Multimodal Data and AIGC: A Case Study on Experience in Diagnosis and Treatment of Lung Cancer with Phlegm-dampness and Blood Stasis Syndrome by Distinguished Traditional Chinese Medicine Physicians of Sichuan School
Resina Draconis Remodels Lewis Lung Carcinoma Microenvironment to Promote Immune Infiltration and Activation and Sensitize Tumors to αPD-1
Related Author
Jian-chao CHENG
Jia-bing TONG
Jie ZHU
Xing-xing ZHANG
Ya-ting GAO
Yang CHEN
Ze-geng LI
Li-li ZHENG
Related Institution
Key Laboratory of Traditional Chinese Medicine(TCM) Prevention and Treatment of Pulmonary Diseases of Anhui Provincial Education Department, Anhui University of Chinese Medicine
Research Institute of Respiratory Diseases of TCM, Anhui Academy of TCM
Longhua Hospital,Shanghai University of Traditional Chinese Medicine
Institute of Basic Research in Clinical Medicine, China Academy of Chinese Medical Sciences
China Resources Double -Crane Limin Pharmaceutical (Jinan) Co.Ltd.


